国际眼科杂志Issue(9)：1546-1549,4.DOI:10.3980/j.issn.1672-5123.2015.9.14
骨髓间充质干细胞应用于角膜疾病的研究进展
Progress of bone marrow mesenchymal stem cells for treatment of corneal diseases
摘要
Abstract
In recent years, with the rapid development of stem cells science, mesenchymal stem cells ( MSCs ) have become a research hotspot. Bone marrow mesenchymal stem cells ( BMSCs ) are MSCs that derived from bone marrow with some advantages, such as the potential of multi- directional differentiation, low immunogenicity, promoting damage repair and stable performance. The study by many scholars found that BMSCs are promising special cells in the field of medicine, and BMSCs have been widely used in almost every system in treatment of disease. For treatment of corneal disease, ophthalmology scholars found that BMSCs have already become a kind of seed cells with clinical and science value. BMSCs brought promising to the patients who have complex corneal disease. In this paper, we introduce the function of BMSCs on the treatment of corneal injury and corneal allograft rejection.关键词
骨髓间充质干细胞/角膜损伤/角膜移植排斥反应Key words
bone marrow mesenchymal stem cells/corneal injury/corneal allograft rejection引用本文复制引用
靳娜,刘红玲,张春梅,傅少颖..骨髓间充质干细胞应用于角膜疾病的研究进展[J].国际眼科杂志,2015,(9):1546-1549,4.基金项目
国家自然科学基金资助项目(No.81301325) （No.81301325）
